Ginkgo Bioworks Holdings WTS (DNABW) Total Assets by Year
Ginkgo Bioworks Holdings WTS closed fiscal year 2025 with $1.1B in total assets, $611.1M in total liabilities and $508.6M in shareholder equity. Total assets fell 18.7% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Ginkgo Bioworks Holdings WTS has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
DNABW Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K |
|---|---|---|---|---|---|---|---|
| Total Assets | $1.1B-18.7% | $1.4B-17.3% | $1.7B-34.4% | $2.5B+22.6% | $2.1B+206.7% | $675.2M-3.2% | $697.3M |
| Total Liabilities | $611.1M-7.6% | $661.4M+16.4% | $568.2M-29.2% | $803.0M+59.5% | $503.6M+145.5% | $205.1M+4.9% | $195.5M |
| Total Equity | $508.6M-29.0% | $716.1M-34.7% | $1.1B-36.8% | $1.7B+15.3% | $1.5B+226.3% | $461.4M-6.4% | $493.1M |
DNABW Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $990.0M-19.6% | $1.0B-20.1% | $1.1B-18.7% | $1.2B-19.7% | $1.2B-24.3% | $1.3B-18.2% | $1.4B-17.3% | $1.5B-26.9% | $1.6B-29.1% | $1.6B-34.6% | $1.7B-34.4% | $2.0B+8.3% |
| Total Liabilities | $569.8M-7.8% | $589.9M-8.7% | $611.1M-7.6% | $629.4M-7.8% | $618.1M-22.0% | $646.0M+8.7% | $661.4M+16.4% | $682.9M-11.7% | $792.2M+0.5% | $594.5M-26.6% | $568.2M-29.2% | $773.7M+79.5% |
| Total Equity | $420.3M-31.4% | $443.2M-31.6% | $508.6M-29.0% | $559.8M-29.8% | $613.0M-26.4% | $647.4M-34.4% | $716.1M-34.7% | $797.9M-36.3% | $833.1M-44.6% | $987.3M-38.6% | $1.1B-36.8% | $1.3B-12.7% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Ginkgo Bioworks Holdings WTS financials
Frequently Asked Questions
Ginkgo Bioworks Holdings WTS closed fiscal year 2025 with $1.1B in total assets, $611.1M in total liabilities and $508.6M in shareholder equity.
Ginkgo Bioworks Holdings WTS (DNABW) total assets fell by 18.7% year over year, from $1.4B to $1.1B in fiscal year 2025.
Across the 7 fiscal years this page covers, Ginkgo Bioworks Holdings WTS (DNABW) total assets went from $697.3M in fiscal year 2019 to $1.1B in fiscal year 2025.
Ginkgo Bioworks Holdings WTS (DNABW) reported $990.0M in total assets in Q2 2026. This represents a decrease of 19.6% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Ginkgo Bioworks Holdings WTS (DNABW) reported on that line in every period on record.